Where can I learn more about this study?
You can find more information about this study on the websites listed below. If more information about the study results is available, it can also be found here.
- www.clinicaltrials.gov. Once you are on the website, type "NCT04488016" into the search box and click "Search".
- www.AstraZenecaClinicalTrials.com. Once you are on the website, type "D8220C00018" into the search box, and click "Find a Study".

Full Study Title: A 2-Part, Phase I, Open-label, Single-dose, Sequential Randomized Crossover Study of New Acalabrutinib Maleate Tablet in Healthy Subjects to Evaluate Relative Bioavailability, Proton Pump Inhibitor (Rabeprazole) Effect, Food Effect and Particle Size Effect
AstraZeneca Protocol Number: D8220C00018
National Clinical Trials Number: NCT04488016
AstraZeneca sponsored this study and has its headquarters in Cambridge, UK.

Thank you!

Clinical study participants belong to a large community of people who take part in clinical research around the world. They help researchers answer important health questions and find medical treatments for patients.

The Center for Information & Study on Clinical Research Participation (CISCRP) is a non-profit organization focused on educating and informing the public about clinical research participation. CISCRP is not involved in recruiting participants for clinical studies, nor is it involved in conducting clinical studies.
CISCRP | One Liberty Square, Suite 1100 â€¢ Boston, MA 02109 | 1-877-MED-HERO | www.ciscrp.org

Version 1.0 2021_09_29